Chest Pain With Active Gastrointestinal Bleeding
62-year-old man with diabetes, hypertension, and a 40-pack-year smoking history presents with two hours of substernal pressure, nausea, and diaphoresis. He is diaphoretic and anxious. BP 152/88, HR 102, SpO2 96%. ECG shows 1.5 mm horizontal ST depression in V4–V6 and T-wave inversion in I and aVL; no ST elevation. High-sensitivity troponin is 0.05 ng/mL at hour 0 (upper reference 0.04) and 0.22 ng/mL at hour 3. Hemoglobin is 7.3 g/dL; he reports two days of black stools. Creatinine 1.3 mg/dL. He took aspirin 325 mg at home. The nearest catheterization laboratory is 30 minutes away.
1. What is the immediate management plan, including antithrombotic choices and timing of angiography? Explain how the gastrointestinal bleeding changes your decisions.
Read the worked answer
Impression: NSTE-ACS with high-risk features (dynamic troponin rise, ST depression, diabetes) plus active gastrointestinal bleeding. He is not in cardiogenic shock, so emergency angiography is not mandatory before stabilization; however, his risk is high enough to warrant an early invasive strategy, generally within 24 hours.
Immediate steps:
- Admit to a monitored bed; obtain serial ECGs and troponins; give oxygen only if hypoxemic.
- Start a proton-pump inhibitor and resuscitate with packed red cells. A restrictive threshold (hemoglobin <7 g/dL, or <8 g/dL if ongoing ischemia or symptoms) is reasonable; overtransfusion can worsen ischemia and volume status.
- Anticoagulate with unfractionated heparin (easier to reverse) rather than fondaparinux; avoid fibrinolysis because of the bleeding risk and because an invasive strategy is available.
- Continue aspirin 81 mg daily. Withhold a P2Y12 inhibitor load until coronary anatomy is known and the bleeding source is addressed, unless the patient destabilizes. If a P2Y12 inhibitor is needed, clopidogrel is the safer choice here than ticagrelor or prasugrel because of the active GI bleed.
- Use radial access if PCI is performed; involve gastroenterology for endoscopy after the patient is stabilized.
Why not just treat the anemia? The troponin rise and ischemic ECG changes indicate myocardial injury from CAD until proven otherwise; anemia is a provocateur, not an alternative diagnosis. Conversely, proceeding with aggressive dual antiplatelet therapy and urgent angiography without addressing the bleed could be fatal. The judgment is to treat both processes in parallel, not sequentially.
2. After endoscopy shows a nonbleeding duodenal ulcer, the patient undergoes successful PCI with a drug-eluting stent in the LAD. What antithrombotic regimen would you prescribe at discharge, and how long would you continue it? How would you modify the plan if he develops recurrent melena?
Read the worked answer
At discharge, prescribe aspirin 81 mg daily plus clopidogrel 75 mg daily, with a proton-pump inhibitor. Avoid prasugrel and, in this bleeding patient, prefer clopidogrel over ticagrelor. Duration: at least 6 months of DAPT after ACS/PCI, then aspirin alone; because he has a high bleeding risk, a shorter DAPT course (3–6 months) followed by single antiplatelet therapy is reasonable if the stent is a modern drug-eluting stent and he remains at high bleeding risk. Do not use triple therapy unless he has another indication for anticoagulation.
If recurrent melena occurs: assess hemodynamics and hemoglobin; hold clopidogrel temporarily while continuing aspirin if possible, because aspirin is important for stent thrombosis prevention; urgent endoscopy; transfuse if indicated. Restart clopidogrel after hemostasis is achieved, usually within a few days. If bleeding is uncontrollable, a strategy of aspirin monotherapy with early resumption of P2Y12 inhibitor after endoscopic control is preferable to stopping all antiplatelet therapy, which risks stent thrombosis. Avoid NSAIDs and add a PPI.